These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 3290700

  • 1. A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration.
    Anderson NE, Budde-Steffen C, Wiley RG, Thurman L, Rosenblum MK, Nadeau SE, Posner JB.
    Neurology; 1988 Jul; 38(7):1018-26. PubMed ID: 3290700
    [Abstract] [Full Text] [Related]

  • 2. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
    Tanaka K, Tanaka M, Igarashi S, Onodera O, Miyatake T, Tsuji S.
    Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
    [Abstract] [Full Text] [Related]

  • 3. [Paraneoplastic cerebellar degeneration].
    Nakano R, Sato S.
    Nihon Rinsho; 1994 Nov; 52(11):3000-5. PubMed ID: 7996701
    [Abstract] [Full Text] [Related]

  • 4. Autoantibodies in paraneoplastic cerebellar degeneration bind to cytoplasmic antigens of Purkinje cells in humans, rats and mice and are of multiple immunoglobulin classes.
    Smith JL, Finley JC, Lennon VA.
    J Neuroimmunol; 1988 Apr; 18(1):37-48. PubMed ID: 3346369
    [Abstract] [Full Text] [Related]

  • 5. Selective concentration of anti-Purkinje cell antibody in the CSF of two patients with paraneoplastic cerebellar degeneration.
    Graus F, Segurado OG, Tolosa E.
    Acta Neurol Scand; 1988 Sep; 78(3):210-3. PubMed ID: 3227806
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration.
    Furneaux HM, Rosenblum MK, Dalmau J, Wong E, Woodruff P, Graus F, Posner JB.
    N Engl J Med; 1990 Jun 28; 322(26):1844-51. PubMed ID: 2348838
    [Abstract] [Full Text] [Related]

  • 10. Anti-Purkinje cell antibody producing B-cell lines from a patient with paraneoplastic cerebellar degeneration.
    Tsukamoto T, Yoshie O, Tada K, Iwasaki Y.
    Arch Neurol; 1987 Aug 28; 44(8):833-7. PubMed ID: 3307712
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ultrastructural localization of anti-Purkinje cell antibody-binding sites in paraneoplastic cerebellar degeneration.
    Hida C, Tsukamoto T, Awano H, Yamamoto T.
    Arch Neurol; 1994 Jun 28; 51(6):555-8. PubMed ID: 8198465
    [Abstract] [Full Text] [Related]

  • 14. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
    Tanaka K, Tanaka M, Onodera O, Tsuji S.
    Rinsho Shinkeigaku; 1995 Jul 28; 35(7):770-4. PubMed ID: 8777801
    [Abstract] [Full Text] [Related]

  • 15. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration.
    Verschuuren J, Chuang L, Rosenblum MK, Lieberman F, Pryor A, Posner JB, Dalmau J.
    Acta Neuropathol; 1996 Jul 28; 91(5):519-25. PubMed ID: 8740233
    [Abstract] [Full Text] [Related]

  • 16. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody].
    Tremouilhac C, Hamy A, De Ferron E, Paineau J, Visset J.
    J Gynecol Obstet Biol Reprod (Paris); 1996 Jul 28; 25(3):253-6. PubMed ID: 8767221
    [Abstract] [Full Text] [Related]

  • 17. Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume.
    Hetzel DJ, Stanhope CR, O'Neill BP, Lennon VA.
    Mayo Clin Proc; 1990 Dec 28; 65(12):1558-63. PubMed ID: 2255217
    [Abstract] [Full Text] [Related]

  • 18. Ovarian carcinoma and paraneoplastic cerebellar degeneration.
    McLellan R, Currie JL, Royal W, Rosenshein NB.
    Obstet Gynecol; 1988 Dec 28; 72(6):922-5. PubMed ID: 3186102
    [Abstract] [Full Text] [Related]

  • 19. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss.
    Tanaka M, Tanaka K, Onodera O, Tsuji S.
    Clin Neurol Neurosurg; 1995 Feb 28; 97(1):95-100. PubMed ID: 7788981
    [Abstract] [Full Text] [Related]

  • 20. Autoimmune paraneoplastic cerebellar degeneration: immunohistological localization of antibody-binding sites.
    Nardelli E, Currò-Dossi B, Rizzuto N, Graus F.
    Clin Neurol Neurosurg; 1995 Feb 28; 97(1):89-94. PubMed ID: 7540522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.